SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-03-001888
Filing Date
2003-09-15
Accepted
2003-09-15 07:58:33
Documents
8
Period of Report
2003-07-31

Document Format Files

Seq Description Document Type Size
1 peregrine_10q-073103.txt 10-Q 98812
3 peregrine_10qex10-87.txt EX-10.87 42382
4 peregrine_10qex10-88.txt EX-10.88 27384
5 peregrine_10qex10-89.txt EX-10.89 43938
6 peregrine_10qex10-90.txt EX-10.90 28196
7 peregrine_10qex31-1.txt EX-31.1 3322
8 peregrine_10qex31-2.txt EX-31.2 3254
9 peregrine_10qex-32.txt EX-32 1508
  Complete submission text file 0001019687-03-001888.txt   251153
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17085 | Film No.: 03894803
SIC: 2835 In Vitro & In Vivo Diagnostic Substances